Article Information
History
- June 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Meshach Asare-Werehene1,2,4,5,
- Michaeline McGuinty3,4,7,
- Agatha Vranjkovic3,4,7,
- Yannick Galipeau3,
- Juthaporn Cowan3,4,5,7,
- Bill Cameron3,4,5,7,
- Curtis L. Cooper3,4,7,
- Marc-André Langlois3,5,
- Angela M. Crawley3,4,5,6,8,9 and
- Benjamin K. Tsang1,2,5,6,*
- 1Departments of Obstetrics & Gynecology, Immunity & Inflammation, University of Ottawa, Ottawa, Ontario, Canada, K1H 8L1
- 2Departments of Cellular & Molecular Medicine, Immunity & Inflammation, University of Ottawa, Ottawa, Ontario, Canada, K1H 8L1
- 3Departments of Biochemistry, Microbiology & Immunology, Immunity & Inflammation, University of Ottawa, Ottawa, Ontario, Canada, K1H 8L1
- 4Departments of Medicine, Immunity & Inflammation, University of Ottawa, Ottawa, Ontario, Canada, K1H 8L1
- 5Departments of Centre for Infection, Immunity & Inflammation, University of Ottawa, Ottawa, Ontario, Canada, K1H 8L1
- 6Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Canada, Ottawa, Ontario, Canada K1H 8L6
- 7Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada, Ottawa, Ontario, Canada K1H 8L6
- 8Department of Biology, Carleton University, Ottawa, Ontario, Canada
- 9Coronavirus Variants Rapid Response Network–Biobank, Canada
- ↵*Correspondence: Dr. Benjamin K Tsang, Chronic Disease Program, Ottawa Hospital Research Institute, The Ottawa Hospital (General Campus), 501 Smyth Road, Ottawa, Canada K1H 8L6; Tel: 1-613-798-5555 ext 72926; Email: btsang{at}ohri.ca
Posted June 02, 2022.
Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes
